DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - clopidogrel

Collection D4 : CTD
Chemical Name clopidogrel ( From PubChem : CLOPIDOGRELUM [LATIN] )
FDA NPC WHO Indian Australia China Traditional
Herbal		 Clinical
Trail
NotNotNotNotNotNotNotNot
Molecular
Weight		 Hydrogen Bond
Donor Count		 Hydrogen Bond
Acceptor Count		 cLogP Lipinski Rule
321.822 g/mol 0 4 3.6118 True
Structure
InChI InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
InChIKey GKTWGGQPFAXNFI-HNNXBMFYSA-N
Links

Gene (24 / 98)


⊖ Less
Source Type Unit Value Gene PMID Assay Other
CTDaffects(reaction)ABCB1
C055162
CTDaffects(response to substance)ABCB1
C055162
CTDaffects(response to substance)ABCB1
C055162
CTDaffects(response to substance)ABCB1
C055162
CTDaffects(response to substance)ABCB1
C055162
CTDdecreases(uptake)ABCB1
C055162
CTDincreases(secretion)ABCB1
C055162
CTDdecreases(activity)ABCB1
C055162
CTDdecreases(expression)ABCB1
C055162
CTDdecreases(secretion)BDNF
C055162
CTDincreases(expression)CCL4
C055162
CTDincreases(expression)CCL5
C055162
CTDdecreases(reaction)CD40LG
C055162
CTDincreases(expression)CD40LG
C055162
CTDincreases(cleavage)CYP1A2
C055162
CTDincreases(oxidation)CYP1A2
C055162
CTDincreases(oxidation)CYP1A2
C055162
CTDdecreases(reaction)CYP1A2
C055162
CTDincreases(oxidation)CYP2B6
C055162
CTDaffects(reaction)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDaffects(phosphorylation)CYP2C19
C055162
CTDaffects(reaction)CYP2C19
C055162
CTDaffects(cotreatment)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDaffects(abundance)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDdecreases(activity)CYP2C19
C055162
CTDdecreases(metabolic processing)CYP2C19
C055162
CTDdecreases(metabolic processing)CYP2C19
C055162
CTDdecreases(response to substance)CYP2C19
C055162
CTDincreases(response to substance)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDincreases(reaction)CYP2C19
C055162
CTDdecreases(metabolic processing)CYP2C19
C055162
CTDdecreases(response to substance)CYP2C19
C055162
CTDincreases(response to substance)CYP2C19
C055162
CTDincreases(activity)CYP2C19
C055162
CTDincreases(metabolic processing)CYP2C19
C055162
CTDincreases(metabolic processing)CYP2C19
C055162
CTDincreases(cleavage)CYP2C19
C055162
CTDincreases(oxidation)CYP2C19
C055162
CTDincreases(oxidation)CYP2C19
C055162
CTDaffects(reaction)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDdecreases(reaction)CYP2C19
C055162
CTDaffects(reaction)CYP2C19
C055162
CTDaffects(response to substance)CYP2C19
C055162
CTDincreases(cleavage)CYP2C8
C055162
CTDincreases(oxidation)CYP2C8
C055162
CTDaffects(reaction)CYP2C9
C055162
CTDaffects(response to substance)CYP2C9
C055162
CTDaffects(response to substance)CYP2C9
C055162
CTDdecreases(metabolic processing)CYP2C9
C055162
CTDincreases(cleavage)CYP2C9
C055162
CTDincreases(oxidation)CYP2C9
C055162
CTDincreases(cleavage)CYP2D6
C055162
CTDincreases(oxidation)CYP2D6
C055162
CTDaffects(response to substance)CYP3A4
C055162
CTDincreases(degradation)CYP3A4
C055162
CTDincreases(cleavage)CYP3A4
C055162
CTDincreases(oxidation)CYP3A4
C055162
CTDincreases(response to substance)CYP3A4
C055162
CTDdecreases(reaction)CYP3A4
C055162
CTDaffects(response to substance)CYP3A5
C055162
CTDincreases(cleavage)CYP3A5
C055162
CTDincreases(oxidation)CYP3A5
C055162
CTDaffects(response to substance)F2R
C055162
CTDincreases(expression)IL6
C055162
CTDincreases(reaction)IL6
C055162
CTDincreases(response to substance)IL6
C055162
CTDaffects(cotreatment)ITGA2
C055162
CTDaffects(response to substance)ITGA2
C055162
CTDaffects(cotreatment)ITGA2
C055162
CTDaffects(response to substance)ITGA2
C055162
CTDaffects(response to substance)ITGB3
C055162
CTDdecreases(response to substance)ITGB3
C055162
CTDdecreases(expression)OCLN
C055162
CTDdecreases(reaction)OCLN
C055162
CTDaffects(binding)P2RY12
C055162
CTDdecreases(activity)P2RY12
C055162
CTDaffects(response to substance)P2RY12
C055162
CTDaffects(reaction)P2RY12
C055162
CTDaffects(response to substance)P2RY12
C055162
CTDaffects(response to substance)P2RY12
C055162
CTDaffects(response to substance)P2RY12
C055162
CTDaffects(response to substance)PON1
C055162
CTDincreases(activity)PON1
C055162
CTDincreases(metabolic processing)PON1
C055162
CTDincreases(expression)THBS1
C055162
CTDincreases(expression)THBS1
C055162
CTDdecreases(expression)TJP1
C055162
CTDdecreases(reaction)TJP1
C055162
CTDincreases(expression)TP53
C055162
CTDaffects(phosphorylation)VASP
C055162
CTDaffects(reaction)VASP
C055162
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).